In chronic rhinosinusitis (CRS) different phenotypes have been reported based on cytokine profile and inflammatory cell patterns. The aim of this study was to characterize the intracytoplasmatic cytokines ofTcells infiltrating theinflamed sinonasal mucosa.
Introduction
Last decenniumthe characterization of T cell subsets has accelerated the understanding of inflammatory and humoral immune responses in part by unveiling the enormous plasticity within these T cell subsets. The balance in T helper subsets as observed in healthy mucosa is disturbed in inflamed mucosa. CD4+ T cells are able to differentiate from naïve T cells into T helper (Th)1, Th2, Th9, Th17, Th22, or Tfollicular helper (Tfh) effector cell subset [1, 2] and this maturation process is largely dependent on antigen presenting cells such as dendritic cells, which mediate their effectvia the release of cytokines and cofactors. Similarly, CD8+ T cells can differentiate to cytotoxic T cell subsets: Tc1, Tc2, Tc17 cells. Moreover, memory T cells are able to switch from one to another type depending on the micro-environmental and mucosal factors [3] .
T helper cell lineage differentiation is mediated by epigenetic processes. For example, naïve CD4 T cell differentiation into Th2 is accompanied by CpGdemethylation and histone modifications within the Th2 locus [4] . Each T cell lineage has distinct molecular, cellular and functional properties. Th2 cells were initially characterized as T cells expressing IL-4, IL-5 and IL-13. Each Th2 cytokine has a well-defined and relatively specific function. IL-4 is the factor driving IgE class switching and alternative macrophage activation, whereas IL-13 functions as an effector molecule that induces physiologic changes of the airways and IL-5 is the major eosinophil activating cytokine [5, 6] . Th1 cells fulfill diverse functions in the immune system by secretion of IFN-c and cytotoxic effects on target, while Th17 and Th22 cells have a very important function in anti-microbial immunity at epithelial/mucosal barriers. Tfh cells regulate the development of antigen-specific B cell immunity [2] .
Chronic rhinosinusitis (CRS) is a highly prevalent inflammation of the nose and the paranasal cavities. CRS can be subdivided in CRS without nasal polyps (CRSsNP) and CRS with nasal polyps (CRSwNP) based on clinical parameters, different cytokine pattern and distinct cellular profiles [7] . Current data on cytokines expression within sinonasal homogenates [8] suggest that maintenance of mucosal health and/or inflammation is not dependent of one T helper cell subset but rather the contribution of several subsets expressed at the same time. Recently different studies demonstrating the presence of IL-5, IL-17 and IFNc, eosinophilic cationic protein (ECP), myeloperoxidase (MPO) and local IgE in homogenatesfrom CRSwNP tissue support the presence of different T cell subsets and consecutive variations in the inflammatory patterns [9, 10] . In CRSsNP however, no IL-5 could be detected on protein level by multiplex analysis, but only IFNc protein could be observed, pointing to Th1 cells as orchestrators.
The aim of this study was to investigate the relative presence of CD4 and CD8 T cells in sinonasal mucosa of healthy controls, CRSsNP and CRSwNP patients and to study intracytoplasmatic expression of cytokines by these T cell populations. This study is describing the different T helper cell populations in healthy and inflamed nasal mucosa by performing polychromatic flow cytometry.
Materials and Methods

Patients
Patients were recruited at the department of Otorhinolaryngology of the Ghent University Hospital, Belgium. Inferior turbinate samples from patients without sinus disease undergoing septoplasty or rhinoseptoplasty were collected as controls (controls n = 7). Samples from patients suffering from chronic rhinosinusitis (CRSsNP n = 9, CRSwNP n = 15 and cystic fibrosis (CF)-NP n = 5) were obtained during functional endoscopic sinus surgery procedures. The study for collecting human tissue samples was approved by the ethical committee of the University of Ghent, Belgium. The number appointed to the study: B67020072535. A written informed consent was obtained by all patients. The diagnosis of sinus disease was based on history, clinical examination, nasal endoscopy and computed tomography of the paranasal cavities according to the current European EPOS guidelines [11] . More detailed information can be found in this article's Online Repository (file S1).
Cytokine Measurements in Tissue Homogenates
Cytokine measurements were performed on tissue homogenates as previously described [12] and were assayed by using the LuminexxMAP suspension array technology in a Bio-Plex 200 system (BioRad, MI, USA). For this, kits for IL-5, IL-17 and IL-1b were purchased from R&D Systems (Minneapolis, USA). Concentrations of IFNc were determined with commercially available ELISA kit (R&D Systems). Total IgE, ECP and specific IgE to staphylococcal enterotoxins (SE-IgE) were measured by the UNICAP system according to manufacturers guidelines (Thermo Fisher Scientific-Phadia, Sweden).
Preparation of Tissue Single Cell Suspension and Stimulation of T Cells
Fresh human nasal mucosa was processed as described as before [12] . To check T cell intracytoplasmatic cytokine expression, nasal mucosa single cells were resuspended in tissue culture medium (TCM, RPMI1640 with 10% FBS). T cells were activated with 50 ng/ml PMA (phorbol 12-myristate 13-acetate) (Sigma) and 1 mg/mlionomycin (Sigma) for 6 hours and incubated at 37uC and 5% CO 2, after 1 hour 3 mg/ml Brefeldin A (ebioscience) was added.
To test the effect of superantigens on T helper cell plasticity, nasal mucosa single cells were stimulated with 0,5 mg/ml Staphylococcus aureus enterotoxin B (Sigma) or TCM for 24 hours and the last 4 hoursPMA/Ionomycin/Brefeldin A was added.
Characterization of T Cell Subtypes
Cells were harvested, centrifuged, washed and ready for intracellular cytokine staining (ICCS) to characterize and define the different T cell subsets. More detailed information can be found in this article's Online Repository (file S1).
Statistics
The data generated in this study were analyzed using the SPSS software version 19. More detailed information can be found in this article's Online Repository (file S1).
Results
Clinical Characterization of Patients and Analysis of Key Cytokines in Sinonasal Tissue
Clinical characteristics of the different samples are described in table 1. Concentrations of IL-4, IL-5 and IgE were significantly higher in the CRSwNP group when compared to control tissue (p,0.01) as shown in table 2. Levels of IL-1b, IL-6, IL-8, IL-17, and IFNc showed no significant difference between control, CRSsNP and CSRwNP groups, while in CF-NP, a significant increase of IL-1b and IL-17 vs. control and CRSwNP was observed.
Phenotypical Characterization of Sinonasal Mucosa T Cells
T cellpopulations present in the nasal mucosa from healthy subjects, CRSsNP, CRSwNP and CF-NP patients were identified as CD3, CD4, CD8, and CD45RA T cellsby using multicolor immunofluorescence staining and flow cytometric analysis. The percentage (%) of CD3+ to total living cells ( Figure 1a 
Cytokine Production by CD4+ T Lymphocytes
The intracellular cytokine pattern was examined by immunofluorescence staining and FACS analysis to delineate Th1, Th2, Th17, Th22 and Tfh cells. Under basal non-stimulated conditions littleto no cytokineswere produced (Figure S1a in file S1). However, after 4 hoursof incubation with PMA/Ionomycin in presence of Brefeldin A, different cytokines could be detected (Figure S1b in File S1) and differences dependent on the disease phenotype (control vs. CRSwNP) were observed. We observed no IL-9 positive T cells (Th9).
The results obtained for the different T helper subsets in control and diseased mucosa are illustrated in Figure 2a 
Cytokine Production by CD8+ T Lymphocytes
Next to CD4+ T cells also the CD8+ T cells produced different cytokines. The major cytokine produced by 60 to 85% of CD8+ T cells was IFNc. In CRSwNP [13, (Figure 1f ). No differences in the number of these cells were found when patients were divided according their atopic or asthma status (data not shown). Moreover, +a small portion of IL-17 producing CD8+ T cells (Tc17 cells) was observed but without differences between the groups, whereas CD8+ expressing IL-4 and/or IL-5 were almost undetectable.
Co-expression of the T Helper Cell Cytokines in Sinus Mucosa
In the Th2 cell population, all IL-5+ CD4T-cells also produced IL-4, while a proportion of IL-4+ cells did not express IL-5. We also observed simultaneous production of IL-17/IFNc, IL-17/IL-22/IFNc, IL-17/IL21 and IFNc/IL-21 ( Figure 3 ) in CD4+ T cell population. Of interest, we could not detect any co-expression of Th2 cytokines (IL-4 or IL-5) with IL-17, IL-22 or IFNc. A few CD4+ IL-4 secreting cells also produced IL-21 ( Figure 3) suggesting the presence of functional T follicular cells in CRSwNP samples. We were able to observe more plasticity in the Th17 cell populationcompared to Th2 cells; however no differences between the disease subgroups were found.
T Helper Cell and Global (Tissue Homogenate) Cytokine Expression
Cytokine results obtained by multiplex analysis on the tissue homogenates was compared with the data collected by flow cytometry. Concentrations for IL-5 protein significantly correlated with the number of Th2 cells observed by FACS (r = 0,856, p, 0,05), indicating that the bulk of this Th2 cytokine is originatedmainly from T cells. The Th2 presence correlated also with an eosinophilic type of CRSwNP (ECP levels) (r = 0,587, p,0,05). The association between tissue IL-17 levels and Th17 cell numbers was significant, but less pronounced (r = 0,454, p,0,05) suggesting sources other than T-cells contribute to the production of this cytokine. For the Th1 cells we were not able to find a correlation because IFNc may not be spontaneously released.
Staphylococcus Enterotoxin B Changes T Cell Cytokine Pattern in CRSwNP
Former ex vivo SEB stimulation experiments with nasal tissue cubes showed a strong release of Th1, Th2 and Th17 cytokines [13] . Here, we questioned if the T cell profiles changed after 24 hours of SEB treatment compared tobaseline. A significant increase of IL-10 producing cells was observedafter SEB treatment [baseline 0,36; IQR: 0,19-0,53 vs. SEB 1,17; IQR: 0,76-1,75] (p = 0,004), as well as anon-significant increase of Th17 cells (Figure 4 ). Other T cell subsets did not change after SEB treatment. 
Discussion
In this study a detailedsubtyping of T cell populations present in diseased and healthy nasal mucosa was conducted by means of flow cytometry. Most T cells in the nasal mucosa were CD45RA negative and of an effector phenotype, which is in agreement with earlier data [14] and in opposite with the T cells circulating in the bloodthatpreferentially carry markers of the naïve T cell phenotype.
In healthy and diseased nasal mucosa a heterogenic population of T helper cells is present: Th1, Th17, Th22, and Tfh cells. The reason for this heterogeneity of effector T cells is mainly related to their protective function, enabling the best type of immune response according to the nature of the invading microorganism [1] . Our results show that the T cell profile of CRSsNP samples was similar to that of control samples, confirmingour earlier hypothesis that CRSsNP is a process of remodeling rather than an inflammatory disease [15] . Strikingly, by means of flow cytometry the Th2 cell subsets could only be detected in CRSwNP samples with the highest levels measured in asthmatic patients. This pattern is consistent with protein dataon homogenized tissue samplesusing multiplex cytokine analysis in a previous study of our lab [9] being corroborated by others [16] . Although IFNc was the major intracytoplasmatic cytokine in T cells, it is almost undetectable in tissue homogenates; obviously, IFNc is not spontaneously released on basal conditions while upon stimulation with SEB or PMA/Ionomycinhigh levels of IFNc could be detected in cell free supernatants. Therefore, Th1 cells are present in CRSwNP mucosal tissue but have to be further triggered to release IFNc. While IL-5 in comparison to IFNc is only expressed by a small proportion of CD4+ T cells, it iseasily detectable in a subgroup of CRSwNP samples and associated with an increase in ECP.
Next to CD4+ T cells, an even larger population of T cells in the nasal mucosa belongs to the CD8 lineage, representing the major sourceof IFNc. independent from suppression of IL-4 producing cells but via the enhancement of Th1 responses [17] . A small percentage of CD8+ T cells expressed IL-17 and ina few nasal polyp samplesIL-5 could be detected. Effector CD8+ T cells are able to attenuate pulmonary inflammation by changing the polarization of T cells to a Th1 phenotype in a Th2 environment [18] , however in asthmatic mice with a strong Th2 response to OVA; a concomitant CD8+ T cells response to viral infection may result in an increase of Tc2 cells, causing lung eosinophilia [17] . Furthermore, Rowe et al. [19] observed in children that IFN-c production by CD8+ T cells may synergize with Th2 cytokines in driving atopy development. The exact functions of Tc1 and Tc2 cells have not been studied in CRS, but our data open perspectives for further research.
In all samples analyzed in this study, a certain co-expression/ plasticity of T helpercells has been observed. Co-expression was especially determined in the Th17 cell population which produced not only IL-17, but also IFNc and IL-22. Some authors annotate these T cells as alternative Th17 cells [20] , these can easily change to a more Th1 phenotype or more Th17 phenotype depending on the external stimuli of the nasal mucosa. In contrast we could not observe Th2 cells producing IL-17 or IFNc which is different from the data found in allergic asthma and atopic dermatitis patients [21] .
Strikingly, although nasal polyps from patients with and without cystic fibrosis patients are morphological alike; they are initiated by different pathomechanisms and occur at different time pointsin life. A pathogen frequently associated with the development of Th2-biased CRSwNP is Staphylococcus aureus, while cystic fibrosis patients are frequently infected by Pseudomonas aeruginosa and are characterized as a Th17 disease [12] . Here weconfirm earlier dataof our group by reporting an increased presence of T cells secreting IL-17 and a large number ofIL-21 secreting T cells in nasal polyps from CF patients.
The data presented resulted from 7 to 15 samples analyzed in the control and CRSwNP groups, respectively, which is accepted in the literature for this kind of pilot biomarker investigation; however, the CF group with only 5 samples has to be considered small. On the basis of this pilot study, sample size calculations can be performed for further studies.
A high variability in Th2 cell cytokine expression was detected in the group of CRSwNP specimens: IL-4 expressing T cells represented 1 to 15% of the CD4+ T cells. Asthmatic patients had the highest number of Th2 cells, this observation also being linked to the expression of SE-IgE antibodies, confirming our earlier analysis based on protein data; those data also showed a great variety of cytokine expression in CRSwNP samples, and a highly increased risk of being asthmatic with the expression of IL-5 and SE-IgE [9] .
Patou et al. [13] who performed ex vivo tissue stimulationexperiments, making use of nasal polyp tissue showed that SEB treatment induced a strong up-regulation of different cytokines including IL-2, IL-4, IL-5, IL-10, TNFa and IFNc. However when treating single cell suspensionsof nasal polyp sampleswith SEBfor 24 hours, we demonstrated that SEB induces anupregulation of T cells secreting IL-10, whereas Tcells expressing other cytokines were not increasing in numbers. IL-10 is an antiinflammatory cytokine that can be expressed by different Th cell subsets, namely Th1, Th2, Th9, Tfh, nTreg, iTreg and Tr1 cells [22, 23] , with theTr-like cells being the most potent source of IL-10. SEB stimulation induced FOXP3 positive T cells (data not shown), however, without anyco-expression of IL-10 in CD4+ T cells. Therefore, iTreg cells are here not a likely source of IL-10. Tr1 cells may have an influence on the Th1/Th2 balance by increasing the development of Th2 cells and decreasing the activity of Th1 cells [24, 25, 26] . This activity of SEB may thus contribute to a persistent Th2 cell bias.
In conclusion this study analyzed the intra-cytoplasmatic cytokine expression of T cells in sinonasal mucosa from healthy and CRS patients, expanding on cytokine protein measurements and supportinga high variability and co-expression of key cytokines. Whereas the majority of CD4+ and CD8+ cells expressed IFNc intracytoplasmatically, IFNc is hardly released without stimulation. Further, Th2 cells within the mucosal tissue, were only observed in nasal polyp patients and were increased in patients suffering from asthma and/or are positive for Staphylococcus aureus enterotoxin-IgE. It will be important to further characterize these obviously active and cytokine secreting Th2 cells and understand their influence in the immunological process. This knowledge may help in the development of newtherapeutic options [27, 28] which wouldreduce the number of Th2 cells, or redirect these Th2 cells into a Th1 phenotype. Tr1 regulatory cells activated by SEB may play a role in the persistence of the mucosal Th2 bias.
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